The largest database of trusted experimental protocols

Accell delivery medium

Manufactured by Horizon Discovery

The Accell Delivery Medium is a laboratory reagent designed for the efficient delivery of nucleic acids, proteins, or other macromolecules into target cells. It facilitates the uptake of these molecules by the cells, enabling their study or manipulation. The product's core function is to enhance the transfection or transduction of cellular systems, providing a tool for researchers working in various fields of cellular and molecular biology.

Automatically generated - may contain errors

6 protocols using accell delivery medium

1

Transfecting Human CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Accell nontargeting pool control siRNA (control siRNAs) and Accell human AKT1 smart pool siRNA (AKT1 siRNAs) were obtained from GE Dharmacon. A total of 20,000 human UCB CD34+ cells were suspended in Accell Delivery Medium (Dharmacon) with cytokines and seeded in 96-well plate. siRNAs were added in a final concentration of 1 μmol/L according to the manufacturer’s instructions (Dharmacon). Cells were transferred to CD34+ basic medium 48 hours after transfection [28 (link)].
+ Open protocol
+ Expand
2

APOBEC and DNASE1 siRNA Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
N/TERT KCs were plated in 96-well plates (30,000 cells/well) and incubated at 37°C with 5% CO2 overnight. Accell siRNA (100 μM; Dharmacon: APOBEC3A, E-017432-00-0005; APOBEC3B, E-017322-01-0005; APOBEC3G, E-013072-00-0005; APOBEC3H, E-019144-00-0005; DNASE1, E-016280-00-0005) was prepared in 1× siRNA buffer (Dharmacon, B-002000-UB-100). One microliter of 100 μM siRNA was diluted with 100 μL Accell delivery medium (Dharmacon, B-005000) for each well of 96-well plates. The growth medium was removed from the cells and 100 μL of the appropriate delivery mix with siRNA was added to each well and the plate was incubated at 37°C with 5% CO2. Accell Non-targeting Control siRNA (Dharmacon, D-001910-01-05) was used as a negative control. After 72 hours, cells were harvested for RNA preparation. RNA isolation and qRT-PCR were as described above.
+ Open protocol
+ Expand
3

siRNA Knockdown of TNFAIP3 in Tregs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For small interfering RNA (siRNA) knockdown of TNFAIP3, Accell SMARTpool siRNA (Dharmacon, Colorado, United States) was used according to the manufacturer's instructions. Briefly, 1 × 105effTreg cells per well were stimulated with αCD3/CD28 beads (1:5 of bead:cell ratio) in Accell Delivery Medium (Dharmacon) supplemented with rhIL-2 (100 U/ml) and incubated with 1 mmol cyclophilin B siRNA (positive control), or 1 mmol non-targeting control siRNA, or 1 mmol TNFAIP3 siRNA for 120 h (for siRNA sequences, see Table S2). Quantitative real-time PCR (RT-qPCR) was performed to confirm the knockdown of the target gene expression.
+ Open protocol
+ Expand
4

Knockdown of STAT5b in Grb10 Murine HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM CD34-KSL cells from Grb10m/+ and Grb10+/+ mice were sorted with a BD ARIA sorter and resuspended in Accell Delivery Medium (Dharmacon) supplemented with 100 ng/ml stem cell factor (SCF, R&D Systems) and 20ng/ml thrombopoietin (TPO, R&D Systems). 1uM Accell siRNA (Dharmacon) targeting STAT5b was added to the medium. At 72 hours after siRNA treatment, cells were then collected and qRT-PCR analysis for STAT5b and Grb10 was performed.
+ Open protocol
+ Expand
5

Differentiation of Pathogenic Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were plated onto anti-CD3 and anti-CD28 coated plates with 12.5 ng/ml mouse rIL-2, anti-IFN-y (10 μg/ml) and anti-IL-4 (5 μg/ml) for 16–18 hours (culture media: IMDM with 10% FBS). Media was then removed and replaced with Accell Delivery Medium (Dharmacon) containing 10% delipidated FBS and cells were differentiated under pathogenic Th17 cell conditions with the addition of 1.5 μM of Accell control siRNA or siRNA targeted to murine siRora and/or siRip2 (Dharmacon). After 48 hours; culture media was replaced with fresh pTh17 cell condition media (IMDM containing 5% FBS). Next day, cells were harvested for qPCR or analyzed by flow cytometry for IL-17A expression.
+ Open protocol
+ Expand
6

TNFAIP3 Knockdown in CD4+ T Memory Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For small interfering RNA (siRNA) knockdown of TNFAIP3, Accell SMARTpool siRNA (Dharmacon, Lafayette, Colo) was used according to the manufacturer's instructions. Briefly, 5 3 10 4 CD4 1 Tmem cells per well were stimulated with aCD3/CD28 beads (1:5 bead/cell ratio) in human serum-free Accell Delivery Medium (Dharmacon) and incubated with Accell siRNA buffer or 1 mmol cyclophilin B (positive control), nontargeting siRNA, or TNFAIP3 siRNA for 6 days (for siRNA sequences, see Table E3 in this article's Online Repository at www.jacionline.org). Quantitative real-time PCR (RT-qPCR) and FACS analysis were performed to confirm the knockdown and cytokine expression in CD4 1 Tmem cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!